EUVIMEDEUVIMED entdecken
Crossref

Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease

Ben Lin iD, Vladimir Melnikov, Sichen Guo, Zhan Cao, Zhao Ye, Zhen Ye, Chenxing Ji iD, Jiajun Chen, Jianxin Wang, Hanwen Zhang, Yiming Jiang, Chengzhang Shi und 13 weitere

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Ben Lin und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China. Hauptthemen laut MEDLINE: Dysbiosis, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Hospital Development Center, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to investigate the gut microbial signatures and related pathophysiological implications in patients with Cushing's disease (CD). Design and methods Twenty-seven patients with CD and 45 healthy controls were enrolled. Based on obtained metagenomics data, we performed correlation, network study, and genome interaction group (GIG) analysis. Fecal metabolomics and serum enzyme linked immunosorbent assay (ELISA) analysis were conducted in dichotomized CD patients. Caco-2 cells were incubated with gradient concentrations of cortisol for subsequent transepithelial electrical resistance (TEER) measurement, FITC-dextran transwell permeability assay, qPCR, and western blot analysis.

Results

Gut microbial composition in patients with CD was notably different from that in healthy controls. Network analysis revealed that Eubacterium siraeum might serve as the core specie in the gut microbial system of CD patients. Subsequent GIG analysis identified the positive correlations between GIG9 and UFC. Further serum ELISA and fecal metabolomics uncovered that CD patients with elevated UFC levels were characterized with increased lipopolysaccharide binding protein (LBP). Moreover, remarkable positive association was found between LBP level and relative abundance of E. siraeum. TEER and FITC-dextran transwell assays demonstrated that hypercortisolism induced increased gut permeability. Further qPCR and western blot analysis suggested that dysregulated AhR/Claudin 2 axis might be involved in the development of hypercortisolism-induced defective gut barrier function Conclusions Disease activity associated dysbiosis and defective gut barrier might jointly facilitate the development of systemic inflammation in patients with CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisGastrointestinal MicrobiomeInflammationHumansMaleFemaleAdultMiddle AgedCaco-2 CellsFecesIntestinal MucosaPituitary ACTH HypersecretionCushing SyndromeCarrier Proteins

Stichwörter der Autor:innen

Cushing’s diseasegut barrierhypercortisolismmicrobiomesystemic inflammation

Substanzen

Carrier Proteins

Autor:innen und Institutionen

  • Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
  • Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, China.
  • Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Department of General Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.
  • Institute of Gut Microbiota Research and Engineering Development, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
  • Department of Nursery, Huashan Hospital West Campus, Jingguang Road No. 958, Shanghai 201104, China.

ORCID-Profile: Ben Lin, Chenxing Ji, Qilin Zhang, Nidan Qiao, Zhaoyun Zhang, Yichao Zhang, Renyuan Gao

Förderung

  • National Natural Science Foundation of China
  • Shanghai Hospital Development Center
  • CAMS Innovation Fund for Medical Sciences
  • National Project for Promoting the Diagnosis and Treatment of Major Diseases
  • MDT

Zitieren

APA

Lin, B., Melnikov, V., Guo, S., Cao, Z., Ye, Z., Ye, Z., Ji, C., Chen, J., Wang, J., Zhang, H., Jiang, Y., Shi, C., Chen, Z., Zhang, Q., Ma, Z., Qiao, N., Chen, L., Wang, M., Wang, Y., …, & Yu, Y. (2024). Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae139

Vancouver

Lin B, Melnikov V, Guo S, Cao Z, Ye Z, Ye Z, et al. Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae139

BibTeX
@article{Lin2024,
  author = {Lin, Ben and Melnikov, Vladimir and Guo, Sichen and Cao, Zhan and Ye, Zhao and Ye, Zhen and Ji, Chenxing and Chen, Jiajun and Wang, Jianxin and Zhang, Hanwen and Jiang, Yiming and Shi, Chengzhang and Chen, Zhengyuan and Zhang, Qilin and Ma, Zengyi and Qiao, Nidan and Chen, Long and Wang, Meng and Wang, Yongfei and Zhang, Zhaoyun and Ye, Hongying and Li, Yiming and Zhang, Yichao and Gao, Renyuan and Yu, Yifei},
  title = {Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae139}
}
Kostenlos starten →